Metraipolis › archive › dc_fabf22a890fa

A Subgroup Analysis of Perioperative Pembrolizumab in Clinical Stage II Non-Small-Cell Lung Cancer from the Randomized KEYNOTE-671 Study — Europe PMC PMID:41875364

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41875364
DOI
10.1093/ejcts/ezag028
License (as archived)
solo-consultazione
Archived
2026-11-05T11:05:59.545Z
SHA-256 of the archived text
8231aefff243d38155197376808d53ce4c3b6f1afe0941a857f3cccc18fa1c4d
Stable URL of this page
https://metraipolis.com/documento/dc_fabf22a890fa

How to cite

A Subgroup Analysis of Perioperative Pembrolizumab in Clinical Stage II Non-Small-Cell Lung Cancer from the Randomized KEYNOTE-671 Study — Europe PMC PMID:41875364 — Europe PMC (en), https://europepmc.org/article/MED/41875364 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fabf22a890fa (Metraipolis archive dc_fabf22a890fa, sha256 8231aefff243d38155197376808d53ce4c3b6f1afe0941a857f3cccc18fa1c4d)
BibTeX
@misc{dcfabf22a890fa,
  title = {A Subgroup Analysis of Perioperative Pembrolizumab in Clinical Stage II Non-Small-Cell Lung Cancer from the Randomized KEYNOTE-671 Study — Europe PMC PMID:41875364},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41875364},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fabf22a890fa; sha256 8231aefff243d38155197376808d53ce4c3b6f1afe0941a857f3cccc18fa1c4d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41875364. Agents can read the archived copy with the MCP tool read_document.